These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 25589495)

  • 1. Syngeneic Murine Ovarian Cancer Model Reveals That Ascites Enriches for Ovarian Cancer Stem-Like Cells Expressing Membrane GRP78.
    Mo L; Bachelder RE; Kennedy M; Chen PH; Chi JT; Berchuck A; Cianciolo G; Pizzo SV
    Mol Cancer Ther; 2015 Mar; 14(3):747-56. PubMed ID: 25589495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modification of the Tumor Microenvironment in KRAS or c-MYC-Induced Ovarian Cancer-Associated Peritonitis.
    Yoshida M; Taguchi A; Kawana K; Adachi K; Kawata A; Ogishima J; Nakamura H; Fujimoto A; Sato M; Inoue T; Nishida H; Furuya H; Tomio K; Arimoto T; Koga K; Wada-Hiraike O; Oda K; Nagamatsu T; Kiyono T; Osuga Y; Fujii T
    PLoS One; 2016; 11(8):e0160330. PubMed ID: 27483433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elimination of head and neck cancer initiating cells through targeting glucose regulated protein78 signaling.
    Wu MJ; Jan CI; Tsay YG; Yu YH; Huang CY; Lin SC; Liu CJ; Chen YS; Lo JF; Yu CC
    Mol Cancer; 2010 Oct; 9():283. PubMed ID: 20979610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A rational approach for cancer stem-like cell isolation and characterization using CD44 and prominin-1(CD133) as selection markers.
    Lee YJ; Wu CC; Li JW; Ou CC; Hsu SC; Tseng HH; Kao MC; Liu JY
    Oncotarget; 2016 Nov; 7(48):78499-78515. PubMed ID: 27655682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microenvironmental effects limit efficacy of thymoquinone treatment in a mouse model of ovarian cancer.
    Wilson AJ; Saskowski J; Barham W; Khabele D; Yull F
    Mol Cancer; 2015 Nov; 14():192. PubMed ID: 26552746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of ascites derived exosomes on the stemness and invasion ability of ovarian cancer stem-like cell].
    Chen SP; Xia YF; Jiang HH; Sun WY; Lou YH
    Zhonghua Fu Chan Ke Za Zhi; 2021 May; 56(5):349-357. PubMed ID: 34034422
    [No Abstract]   [Full Text] [Related]  

  • 7. GRP78 secreted by tumor cells stimulates differentiation of bone marrow mesenchymal stem cells to cancer-associated fibroblasts.
    Peng Y; Li Z; Li Z
    Biochem Biophys Res Commun; 2013 Nov; 440(4):558-63. PubMed ID: 24113381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CXCL10 alters the tumour immune microenvironment and disease progression in a syngeneic murine model of high-grade serous ovarian cancer.
    K Au K; Peterson N; Truesdell P; Reid-Schachter G; Khalaj K; Ren R; Francis JA; Graham CH; Craig AW; Koti M
    Gynecol Oncol; 2017 Jun; 145(3):436-445. PubMed ID: 28318643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PPARγ activation modulates the balance of peritoneal macrophage populations to suppress ovarian tumor growth and tumor-induced immunosuppression.
    Prat M; Coulson K; Blot C; Jacquemin G; Romano M; Renoud ML; AlaEddine M; Le Naour A; Authier H; Rahabi MC; Benmoussa K; Salon M; Parny M; Delord JP; Ferron G; Lefèvre L; Couderc B; Coste A
    J Immunother Cancer; 2023 Aug; 11(8):. PubMed ID: 37586764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of Krüppel-like factor 9 facilitates stemness in ovarian cancer ascites-derived multicellular spheroids via Notch1/slug signaling.
    Wang K; Liu S; Dou Z; Zhang S; Yang X
    Cancer Sci; 2021 Oct; 112(10):4220-4233. PubMed ID: 34363722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization and evaluation of pre-clinical suitability of a syngeneic orthotopic mouse ovarian cancer model.
    Cho S; Sun Y; Soisson AP; Dodson MK; Peterson CM; Jarboe EA; Kennedy AM; Janát-Amsbury MM
    Anticancer Res; 2013 Apr; 33(4):1317-24. PubMed ID: 23564768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thymoquinone enhances cisplatin-response through direct tumor effects in a syngeneic mouse model of ovarian cancer.
    Wilson AJ; Saskowski J; Barham W; Yull F; Khabele D
    J Ovarian Res; 2015 Jul; 8():46. PubMed ID: 26215403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Losartan treatment enhances chemotherapy efficacy and reduces ascites in ovarian cancer models by normalizing the tumor stroma.
    Zhao Y; Cao J; Melamed A; Worley M; Gockley A; Jones D; Nia HT; Zhang Y; Stylianopoulos T; Kumar AS; Mpekris F; Datta M; Sun Y; Wu L; Gao X; Yeku O; Del Carmen MG; Spriggs DR; Jain RK; Xu L
    Proc Natl Acad Sci U S A; 2019 Feb; 116(6):2210-2219. PubMed ID: 30659155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of M2-like macrophages in the progression of ovarian cancer.
    Baek SH; Lee HW; Gangadaran P; Oh JM; Zhu L; Rajendran RL; Lee J; Ahn BC
    Exp Cell Res; 2020 Oct; 395(2):112211. PubMed ID: 32755554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ascites Increases Expression/Function of Multidrug Resistance Proteins in Ovarian Cancer Cells.
    Mo L; Pospichalova V; Huang Z; Murphy SK; Payne S; Wang F; Kennedy M; Cianciolo GJ; Bryja V; Pizzo SV; Bachelder RE
    PLoS One; 2015; 10(7):e0131579. PubMed ID: 26148191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell surface GRP78 promotes stemness in normal and neoplastic cells.
    Conner C; Lager TW; Guldner IH; Wu MZ; Hishida Y; Hishida T; Ruiz S; Yamasaki AE; Gilson RC; Belmonte JCI; Gray PC; Kelber JA; Zhang S; Panopoulos AD
    Sci Rep; 2020 Feb; 10(1):3474. PubMed ID: 32103065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autocrine interleukin-23 promotes self-renewal of CD133+ ovarian cancer stem-like cells.
    Wang D; Xiang T; Zhao Z; Lin K; Yin P; Jiang L; Liang Z; Zhu B
    Oncotarget; 2016 Nov; 7(46):76006-76020. PubMed ID: 27738346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Notch3 signaling promotes tumor cell adhesion and progression in a murine epithelial ovarian cancer model.
    Price JC; Azizi E; Naiche LA; Parvani JG; Shukla P; Kim S; Slack-Davis JK; Pe'er D; Kitajewski JK
    PLoS One; 2020; 15(6):e0233962. PubMed ID: 32525899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ovarian Cancer Stem Cells with High ROR1 Expression Serve as a New Prophylactic Vaccine for Ovarian Cancer.
    Wu D; Yu X; Wang J; Hui X; Zhang Y; Cai Y; Ren M; Guo M; Zhao F; Dou J
    J Immunol Res; 2019; 2019():9394615. PubMed ID: 31008116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimulating TAM-mediated anti-tumor immunity with mannose-decorated nanoparticles in ovarian cancer.
    Glass EB; Hoover AA; Bullock KK; Madden MZ; Reinfeld BI; Harris W; Parker D; Hufnagel DH; Crispens MA; Khabele D; Rathmell WK; Rathmell JC; Wilson AJ; Giorgio TD; Yull FE
    BMC Cancer; 2022 May; 22(1):497. PubMed ID: 35513776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.